Selecting the right solid form early can significantly reduce risk in solid oral drug development. In this application note, Ardena shares a case study demonstrating how comprehensive experimental polymorph screening, combined with structural informatics using crystal structure database insights, supports confident selection of the most thermodynamically stable polymorph. The approach strengthens development decisions by balancing stability, processability, and performance from the start.
